drug sequencing

You have access
Third-line Enzalutamide Following Docetaxel and Abiraterone in Metastatic Castrate-resistant Prostate Cancer
RHIAN SIÂN DAVIES, CHRISTIAN SMITH and JASON FRANCIS LESTER

Anticancer Research April 2016, 36 (4) 1799-1803;
You have access
What Predicts Minimal Response to Abiraterone in Metastatic Castrate-resistant Prostate Cancer?
RHIAN SIÂN DAVIES, CHRISTIAN SMITH, MICHAEL ROBERT BUTTON, JACOB TANGUAY, JIM BARBER, NACHIAPPAN PALANIAPPAN, JOHN STAFFURTH and JASON FRANCIS LESTER

Anticancer Research October 2015, 35 (10) 5615-5621;

Main menu